RRRabindra Roy

Rabindra Roy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rabindra Roy has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Sanjay Adhikari

    Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States

    12 shared publications
  • Jordan Woodrick

    Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

    8 shared publications
  • Aykut Üren

    From the Molecular Oncology Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D. C. 20057

    6 shared publications
  • Suhani Gupta

    Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA

    6 shared publications
  • Sujata Choudhury

    Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA

    5 shared publications
  • Pooja Khatkar

    Laboratory of Molecular Virology, George Mason University, Manassas, VA 20110, USA

    4 shared publications

Latest Publications

  • Open Access

    A Multi-Gene Signature Associated with 1-Year Survival in Patients with Stage I Liver Cancer: Integration of Preclinical and TCGA Data

    by Ritam Adhikari, Bhaskar V. S. Kallakury, Chiranjeev Dash, Rabindra Roy

    Approximately 50% of individuals diagnosed with Stage I liver cancer live beyond four years; however, a small subset of Stage I patients die within the first year. A prognostic biomarker panel that can identify high-risk Stage I patients may be extremely valuable. In this study, we used the Long–Evans Cinnamon (LEC) rat model of Wilson’s Disease and hepatocellular carcinoma (HCC), along with data from The Cancer Genome Atlas (TCGA) human database, to create a novel biomarker panel. We generated and analyzed a rat microarray gene expression profile by comparing liver tumor tissues with adjacent normal tissues from the same animals, covering approximately 30,000 genes. The microarray results were translated into a five-gene panel associated with 1-year survival in Stage I liver cancer patients based on TCGA data, in combination with machine learning and bioinformatics approaches. The panel was internally validated following the “REporting recommendations for Tumor MARKer prognostic studies (REMARK)” guidelines. With no existing Stage-I-specific prognostic tools, a biomarker panel associated with 1-year survival in patients with Stage I liver cancer is a potential candidate for rigorous external validation.

  • Open Access

    Beyond Nucleotide Excision Repair: The Importance of XPF in Base Excision Repair and Its Impact on Cancer, Inflammation, and Aging

    by Dhara Gohil, Rabindra Roy

    DNA repair involves various intricate pathways that work together to maintain genome integrity. XPF (ERCC4) is a structural endonuclease that forms a heterodimer with ERCC1 that is critical in both single-strand break repair (SSBR) and double-strand break repair (DSBR). Although the mechanistic function of ERCC1/XPF has been established in nucleotide excision repair (NER), its role in long-patch base excision repair (BER) has recently been discovered through the 5′-Gap pathway. This study briefly explores the roles of XPF in different pathways to emphasize the importance of XPF in DNA repair. XPF deficiency manifests in various diseases, including cancer, neurodegeneration, and aging-related disorders; it is also associated with conditions such as Xeroderma pigmentosum and fertility issues. By examining the molecular mechanisms and pathological consequences linked to XPF dysfunction, this study aims to elucidate the crucial role of XPF in genomic stability as a repair protein in BER and provide perspectives regarding its potential as a therapeutic target in related diseases.


  • Open Access

    Systemic DNA Damage and Repair Activity Vary by Race in Breast Cancer Survivors

    by Shraddha Divekar, Ryan Kritzer, Haokai Shu, Keval Thakkar, Jennifer Hicks, Mary G. Mills, Kepher Makambi, Chiranjeev Dash, Rabindra Roy

    Non-Hispanic Black breast cancer survivors have poorer outcomes and higher mortality rates than White survivors, but systemic biological mechanisms underlying these disparities are unclear. We used circulating leukocytes as a surrogate for measuring systemic mechanisms, which might be different from processes in the target tissue (e.g., breast). We investigated race-based differences in DNA damage and repair, using a novel CometChip assay, in circulating leukocytes from breast cancer survivors who had completed primary cancer therapy and were cancer free. We observed novel race-based differences in systemic DNA damage and repair activity in cancer survivors, but not in cells from healthy volunteers. Basal DNA damage in leukocytes was higher in White survivors, but Black survivors showed a much higher induction after bleomycin treatment. Double-strand break repair activity was also significantly different between the races, with cells from White survivors showing more sustained repair activity compared to Black leukocytes. These results suggest that cancer and cancer therapy might have long-lasting effects on systemic DNA damage and repair mechanisms that differ in White survivors and Black survivors. Findings from our preliminary study in non-cancer cells (circulating leukocytes) suggest systemic effects beyond the target site, with implications for accelerated aging-related cancer survivorship disparities.


  • Top Cited Papers
    Open Access

    Base Excision Repair: Mechanisms and Impact in Biology, Disease, and Medicine

    by Dhara Gohil, Altaf H. Sarker, Rabindra Roy

    Base excision repair (BER) corrects forms of oxidative, deamination, alkylation, and abasic single-base damage that appear to have minimal effects on the helix. Since its discovery in 1974, the field has grown in several facets: mechanisms, biology and physiology, understanding deficiencies and human disease, and using BER genes as potential inhibitory targets to develop therapeutics. Within its segregation of short nucleotide (SN-) and long patch (LP-), there are currently six known global mechanisms, with emerging work in transcription- and replication-associated BER. Knockouts (KOs) of BER genes in mouse models showed that single glycosylase knockout had minimal phenotypic impact, but the effects were clearly seen in double knockouts. However, KOs of downstream enzymes showed critical impact on the health and survival of mice. BER gene deficiency contributes to cancer, inflammation, aging, and neurodegenerative disorders. Medicinal targets are being developed for single or combinatorial therapies, but only PARP and APE1 have yet to reach the clinical stage.


  • Simultaneous Short- and Long-Patch Base Excision Repair (BER) Assay in Live Mammalian Cells

    by Rabindra Roy

    The base excision repair (BER) pathway repairs small, non-bulky DNA lesions, including oxidized, alkylated, and deaminated bases, and is responsible for the removal of at least 20,000 DNA lesions per cell per day. BER is initiated by DNA damage-specific DNA glycosylases that excise the damaged base and generates an abasic (AP) site or single-strand breaks, which are subsequently repaired in mammalian cells either by single-nucleotide (SN) or multiple-nucleotide incorporation via the SN-BER or long-patch BER (LP-BER) pathway, respectively. This chapter describes a plaque-based host cell reactivation (PL-HCR) assay system for measuring BER mechanisms in live mammalian cells using a plasmid-based assay. After transfection of a phagemid (M13mp18) containing a single modified base (representative BER DNA substrates) within a restriction site into human cells, restriction digestions detect the presence or absence (complete repair) of the adduct by the transformation of the digestion products into E. coli and counting the transformants as plaques. To monitor the patch size, different plasmids are constructed containing C:A mismatches within different restriction sites (inhibiting digestion) at various distances on both sides (5′ or 3′) of the modified base-containing restriction sites. Using this assay, the percentage of repair events that occur via 5′ and 3′ patch formation can be quantified.


  • A new sub‐pathway of long‐patch base excision repair involving 5′ gap formation

    by Jordan Woodrick, Suhani Gupta, Sharon Camacho, Swetha Parvathaneni, Sujata Choudhury, Amrita Cheema, Yi Bai, Pooja Khatkar, Hayriye Verda Erkizan, Furqan Sami, et al.

    Base excision repair (BER) is one of the most frequently used cellular DNA repair mechanisms and modulates many human pathophysiological conditions related to DNA damage. Through live cell and in vitro reconstitution experiments, we have discovered a major sub‐pathway of conventional long‐patch BER that involves formation of a 9‐nucleotide gap 5′ to the lesion. This new sub‐pathway is mediated by RECQ1 DNA helicase and ERCC1‐XPF endonuclease in cooperation with PARP1 poly(ADP‐ribose) polymerase and RPA. The novel gap formation step is employed during repair of a variety of DNA lesions, including oxidative and alkylation damage. Moreover, RECQ1 regulates PARP1 auto‐(ADP‐ribosyl)ation and the choice between long‐patch and single‐nucleotide BER, thereby modulating cellular sensitivity to DNA damage. Based on these results, we propose a revised model of long‐patch BER and a new key regulation point for pathway choice in BER. Synopsis DNA base excision repair (BER) is essential for coping with highly frequent oxidative and alkylation base damage. Identification of a novel sub‐pathway argues for a revision of mammalian long‐patch BER models and suggests a new key regulation point in BER pathway choice. Live cell and in vitro reconstitution experiments reveal formation of a 9‐nucleotide gap 5′ to the lesion. Gap formation happens during repair of various DNA lesions, including oxidative and alkylation damage. Gap formation involves the specific actions of PARP1, RECQ1 helicase, RPA and ERCC1‐XPF endonuclease. RECQ1 inhibits PARP1 auto‐PARylation to suppress single‐nucleotide BER in favor of gap‐mediated long‐patch BER.


  • Corrigendum to “Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease” [Bioorg. Med. Chem. 23 (2015) 1102–1111]

    by Monica Dixon, Jordan Woodrick, Suhani Gupta, Soumendra Krishna Karmahapatra, Stephen Devito, Sona Vasudevan, Sivanesan Dakshanamurthy, Sanjay Adhikari, Venkata M. Yenugonda, Rabindra Roy

  • A novel method for monitoring functional lesion-specific recruitment of repair proteins in live cells

    by Jordan Woodrick, Suhani Gupta, Pooja Khatkar, Kalpana Dave, Darya Levashova, Sujata Choudhury, Hadi Elias, Tapas Saha, Susette Mueller, Rabindra Roy


  • Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease

    by Monica Dixon, Jordan Woodrick, Suhani Gupta, Soumendra Krishna Karmahapatra, Stephen Devito, Sona Vasudevan, Sivanesan Dakshanamurthy, Sanjay Adhikari, Venkata M. Yenugonda, Rabindra Roy